· NY legislature · 2025-2026

Relates to the labeling of mifepristone, misoprostol, and their generic alternatives

Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.

Sponsor

Karines Reyes (D-NY)

Introduced

2025-01-15

Policy area

Health

Latest action

SUBSTITUTED BY S36A